WASHINGTON, Dec. 29 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs.

The notice was published in the Federal Register on Dec. 29 by Brian Fahey, Associate Commissioner for Legislation.

Summary: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

For more information, contact Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10...